A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.
Clinical trial NCT05878691 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05878691
- Sponsor
- Glenmark Specialty S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2027-07-30
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.